Market research

Used Medical Imaging Equipment

Explore licenses

360iResearch introduction

Used Medical Imaging Equipment: Executive Overview

Used medical imaging equipment supports healthcare providers seeking access to diagnostic technologies while managing capital constraints, replacement needs, and uneven equipment availability. The category includes refurbished, remanufactured, and pre-owned systems such as magnetic resonance imaging, computed tomography, X-ray, ultrasound, and nuclear imaging equipment. Purchasing decisions depend on clinical requirements, equipment condition, serviceability, regulatory compliance, installation infrastructure, and the availability of parts and trained technicians.

Inside the research

Coverage at a glance

Selected branches from the published table of contents. Follow a chapter to explore its complete hierarchy.

  1. Chapter 7 Component Type

    • Complete Imaging Systems
    • Detectors and Transducers
    • Tubes and High-Value Components
    • Consoles and Workstations
    More in this chapter
  2. Chapter 8 Modality

    • X-Ray Systems
    • Computed Tomography Systems
    • Magnetic Resonance Imaging Systems
    • Ultrasound Systems
    More in this chapter
  3. Chapter 9 Imaging Technology

    • Analog Imaging
    • Digital Imaging
    • 2D Imaging
    • 3D and 4D Imaging
    View chapter

How Refurbishment and Access Models Are Reshaping Imaging

The landscape is shifting from simple equipment resale toward documented refurbishment, lifecycle management, and service-supported deployment. Buyers increasingly require inspection records, performance testing, software and cybersecurity documentation, warranties, installation support, and reliable maintenance pathways. Demand is also influenced by hospital expansion, replacement of aging systems, outpatient diagnostic growth, and efforts to extend the useful life of installed equipment. These developments raise the importance of transparent grading standards and traceable equipment histories.

Artificial Intelligence Raises Both Value and Verification Requirements

Artificial intelligence is changing imaging workflows through computer-assisted detection, image reconstruction, protocol optimization, triage, and operational scheduling. For used equipment, AI adoption increases the value of systems that can support current software, compatible workstations, adequate processing capacity, and secure data exchange. It also introduces verification requirements: buyers must assess software licensing, interoperability, update support, cybersecurity controls, and whether legacy hardware can meet the technical requirements of newer algorithms. AI therefore strengthens the case for lifecycle due diligence rather than equipment-price comparisons alone.

Regional Insights: Uneven Access and Distinct Procurement Priorities

North America emphasizes regulatory documentation, interoperability, cybersecurity, and service continuity, while Latin America often places greater weight on affordability, import procedures, financing, and access to local technical support. Europe combines mature clinical infrastructure with strong attention to safety, data protection, environmental performance, and cross-border compliance. The Middle East is shaped by healthcare infrastructure investment, specialist capacity, and the need for dependable installation and maintenance. Africa includes highly varied procurement environments, where robust equipment, training, parts availability, and adaptable service models are especially important. Asia-Pacific spans advanced replacement markets and rapidly expanding healthcare systems, creating demand for both sophisticated refurbished platforms and dependable entry-level imaging capacity.

Group Insights: Policy, Trade, and Infrastructure Shape Adoption

ASEAN markets present diverse regulatory, infrastructure, and financing conditions, making regional service networks and adaptable deployment models valuable. BRICS countries combine substantial healthcare demand with different domestic manufacturing, import, and reimbursement environments, requiring market-specific compliance and support strategies. The European Union places emphasis on harmonized safety, documentation, data governance, and sustainability requirements. G7 procurement environments generally prioritize clinical performance, cybersecurity, interoperability, and accountable servicing. GCC healthcare systems often focus on advanced clinical capability, rapid deployment, and high service reliability. NATO members may give additional attention to supply-chain resilience, interoperability, secure information systems, and continuity of medical operations.

Country Insights: Diverse Requirements Across Major Healthcare Systems

Australia and Canada require solutions suited to geographically dispersed care delivery and dependable logistics. Brazil and Mexico balance affordability with regulatory clearance, local servicing, and uneven access across regions. China and India combine large and varied healthcare systems with strong interest in capacity expansion, local compliance, and cost-effective lifecycle management. France, Germany, Italy, Spain, and the United Kingdom operate within mature regulatory and clinical environments where documentation, safety, interoperability, and maintenance records are central purchasing considerations. Japan and South Korea place high value on technical quality, precision, workflow integration, and reliable support. Russia’s operating environment is shaped by procurement constraints, servicing access, and supply-chain considerations. In the United States, buyers commonly emphasize accreditation, cybersecurity, compatibility with clinical information systems, warranty terms, and total cost of ownership.

Recommendations for Leaders: Buy for Clinical Continuity, Not Initial Price

Industry leaders should establish a standardized acceptance protocol covering image quality, radiation or magnetic-field safety where relevant, component condition, software versions, service history, and compliance records. Total cost analysis should include transportation, site preparation, installation, calibration, training, maintenance, parts, downtime, and eventual disposal. Buyers should verify interoperability with picture archiving and communication systems, radiology information systems, electronic health records, and emerging AI tools. A documented cybersecurity review, clear warranty and service-level terms, and a parts-availability plan can reduce operational risk. Providers should also match modality selection to referral volumes, clinical priorities, workforce capability, and local infrastructure rather than treating all used systems as interchangeable.

Research Methodology: Evidence-Based Assessment of Equipment Adoption Conditions

This executive summary uses a structured qualitative assessment of the used medical imaging equipment ecosystem. The analysis considers modality requirements, refurbishment and resale practices, healthcare infrastructure, procurement behavior, regulatory and safety obligations, service capacity, interoperability, cybersecurity, and the role of artificial intelligence. Regional, group, and country observations are integrated from publicly documented institutional, regulatory, health-system, and technology considerations. Conclusions are framed as market dynamics and decision factors; no market estimates, market shares, or forecasts are used.

Conclusion: Reliability and Lifecycle Support Define Sustainable Value

Used medical imaging equipment can improve access to diagnostic capacity when procurement is supported by rigorous technical verification, regulatory diligence, skilled installation, and dependable long-term service. The strongest value proposition is not the lowest acquisition price, but reliable clinical performance over the equipment’s remaining useful life. As AI, interoperability, cybersecurity, and sustainability become more important, refurbishment quality and lifecycle transparency will increasingly determine whether pre-owned systems deliver safe, practical, and durable healthcare benefits.

Research report

Table of contents

  1. 1.Preface
    1. 1.1Objectives of the Study
    2. 1.2Market Definition
    3. 1.3Market Segmentation & Coverage
    4. 1.4Years Considered for the Study
    5. 1.5Currency Considered for the Study
    6. 1.6Language Considered for the Study
    7. 1.7Key Stakeholders
  2. 2.Research Methodology
    1. 2.1Introduction
    2. 2.2Research Design
      1. 2.2.1Primary Research
      2. 2.2.2Secondary Research
    3. 2.3Research Framework
      1. 2.3.1Qualitative Analysis
      2. 2.3.2Quantitative Analysis
    4. 2.4Market Size Estimation
      1. 2.4.1Top-Down Approach
      2. 2.4.2Bottom-Up Approach
    5. 2.5Data Triangulation
    6. 2.6Research Outcomes
    7. 2.7Research Assumptions
    8. 2.8Research Limitations
  3. 3.Executive Summary
    1. 3.1Introduction
    2. 3.2CXO Perspective
    3. 3.3New Revenue Opportunities
    4. 3.4Next-Generation Business Models
    5. 3.5Industry Roadmap
  4. 4.Market Overview
    1. 4.1Introduction
    2. 4.2Industry Ecosystem & Value Chain Analysis
      1. 4.2.1Supply-Side Analysis
      2. 4.2.2Demand-Side Analysis
      3. 4.2.3Stakeholder Analysis
    3. 4.3Market Dynamics
      1. 4.3.1Key Drivers
      2. 4.3.2Key Restraints
      3. 4.3.3Key Opportunities
      4. 4.3.4Key Challenges
    4. 4.4Porter’s Five Forces Analysis
    5. 4.5PESTLE Analysis
    6. 4.6Market Outlook
      1. 4.6.1Near-Term Market Outlook (0–2 Years)
      2. 4.6.2Medium-Term Market Outlook (3–5 Years)
      3. 4.6.3Long-Term Market Outlook (5–10 Years)
    7. 4.7Go-to-Market Strategy
  5. 5.Market Insights
    1. 5.1Consumer Insights & End-User Perspective
    2. 5.2Consumer Experience Benchmarking
    3. 5.3Opportunity Mapping
    4. 5.4Distribution Channel Analysis
    5. 5.5Pricing Trend Analysis
    6. 5.6Regulatory Compliance & Standards Framework
    7. 5.7ESG & Sustainability Analysis
    8. 5.8Disruption & Risk Scenarios
    9. 5.9Return on Investment & Cost-Benefit Analysis
  6. 6.Cumulative Impact of Artificial Intelligence 2026
  7. 7.Used Medical Imaging Equipment Market, by Component Type
    1. 7.1Introduction
    2. 7.2Complete Imaging Systems
    3. 7.3Detectors and Transducers
      1. 7.3.1X-Ray Detectors
      2. 7.3.2Ultrasound Transducers
      3. 7.3.3MRI Coils
    4. 7.4Tubes and High-Value Components
      1. 7.4.1X-Ray Tubes
      2. 7.4.2CT Tubes
    5. 7.5Consoles and Workstations
    6. 7.6Upgrades and Retrofits
      1. 7.6.1Software Upgrades
      2. 7.6.2Hardware Upgrades
    7. 7.7Spare Parts and Accessories
      1. 7.7.1Patient Handling Accessories
      2. 7.7.2Cables and Connectors
      3. 7.7.3Power and Cooling Units
  8. 8.Used Medical Imaging Equipment Market, by Modality
    1. 8.1Introduction
    2. 8.2X-Ray Systems
      1. 8.2.1General Radiography Systems
      2. 8.2.2Fluoroscopy Systems
      3. 8.2.3Mammography Systems
      4. 8.2.4Digital Radiography Systems
      5. 8.2.5Computed Radiography Systems
    3. 8.3Computed Tomography Systems
      1. 8.3.11 to 16 Slice CT
      2. 8.3.232 to 64 Slice CT
      3. 8.3.3128 Slice and Above CT
      4. 8.3.4Cone Beam CT Systems
    4. 8.4Magnetic Resonance Imaging Systems
      1. 8.4.1Less Than 1.0T MRI
      2. 8.4.21.0T to 1.5T MRI
      3. 8.4.33.0T and Above MRI
      4. 8.4.4Open MRI Systems
    5. 8.5Ultrasound Systems
      1. 8.5.1Cart-Based Ultrasound
      2. 8.5.2Portable Ultrasound
      3. 8.5.3Handheld Ultrasound
    6. 8.6Nuclear Imaging Systems
    7. 8.7Interventional and Angiography Systems
  9. 9.Used Medical Imaging Equipment Market, by Imaging Technology
    1. 9.1Introduction
    2. 9.2Analog Imaging
    3. 9.3Digital Imaging
      1. 9.3.1Direct Digital Imaging
      2. 9.3.2Computed Radiography Imaging
    4. 9.42D Imaging
    5. 9.53D and 4D Imaging
  10. 10.Used Medical Imaging Equipment Market, by Product Condition
    1. 10.1Introduction
    2. 10.2Refurbished Equipment
      1. 10.2.1OEM-Certified Refurbished Equipment
      2. 10.2.2Independent Refurbished Equipment
    3. 10.3Reconditioned Equipment
    4. 10.4Used As-Is Equipment
    5. 10.5Demo and Ex-Showroom Equipment
  11. 11.Used Medical Imaging Equipment Market, by Installation Type
    1. 11.1Introduction
    2. 11.2Fixed Installation Systems
    3. 11.3Mobile Installation Systems
      1. 11.3.1Van or Truck-Mounted Mobile Units
      2. 11.3.2Trailer-Based Mobile Units
    4. 11.4Portable Installation Systems
      1. 11.4.1Cart-Mounted Portable Systems
      2. 11.4.2Hand-Carried Portable Systems
  12. 12.Used Medical Imaging Equipment Market, by Clinical Application
    1. 12.1Introduction
    2. 12.2Oncology Imaging
    3. 12.3Cardiology Imaging
    4. 12.4Neurology Imaging
    5. 12.5Orthopedics and Musculoskeletal Imaging
    6. 12.6Obstetrics and Gynecology Imaging
    7. 12.7Abdominal and General Imaging
    8. 12.8Emergency and Critical Care Imaging
  13. 13.Used Medical Imaging Equipment Market, by End User
    1. 13.1Introduction
    2. 13.2Hospitals
      1. 13.2.1Public and Academic Hospitals
      2. 13.2.2Private Hospitals
    3. 13.3Diagnostic Imaging Centers
    4. 13.4Ambulatory Surgical Centers
    5. 13.5Specialty Clinics
    6. 13.6Mobile Imaging Service Providers
    7. 13.7Veterinary Clinics and Hospitals
    8. 13.8Research and Academic Institutes
  14. 14.Used Medical Imaging Equipment Market, by Region
    1. 14.1Introduction
    2. 14.2Asia-Pacific
    3. 14.3North America
    4. 14.4Latin America
    5. 14.5Europe
    6. 14.6Middle East
    7. 14.7Africa
  15. 15.Used Medical Imaging Equipment Market, by Group
    1. 15.1Introduction
    2. 15.2ASEAN
    3. 15.3GCC
    4. 15.4European Union
    5. 15.5BRICS
    6. 15.6G7
    7. 15.7NATO
  16. 16.Used Medical Imaging Equipment Market, by Country
    1. 16.1Introduction
    2. 16.2United States
    3. 16.3Canada
    4. 16.4Mexico
    5. 16.5Brazil
    6. 16.6United Kingdom
    7. 16.7Germany
    8. 16.8France
    9. 16.9Russia
    10. 16.10Italy
    11. 16.11Spain
    12. 16.12China
    13. 16.13India
    14. 16.14Japan
    15. 16.15Australia
    16. 16.16South Korea
  17. 17.Competitive Landscape
    1. 17.1Market Share Analysis, 2025
    2. 17.2Market Concentration Analysis, 2025
      1. 17.2.1Concentration Ratio (CR)
      2. 17.2.2Herfindahl Hirschman Index (HHI)
    3. 17.3Recent Developments & Impact Analysis, 2025
    4. 17.4Product Portfolio Analysis, 2025
    5. 17.5Benchmarking Analysis, 2025
  18. 18.Company Profiles
    1. 18.1Agito Medical A/S
    2. 18.2Avante Health Solutions, Inc.
    3. 18.3Block Imaging, Inc.
    4. 18.4Canon Medical Systems Corporation
    5. 18.5Carestream Health, Inc.
    6. 18.6DRE Medical, Inc.
    7. 18.7EverX Pty Ltd.
    8. 18.8Fair Medical Co. Ltd.
    9. 18.9Fujifilm Holdings Corporation
    10. 18.10Future Health Concepts, Inc.
    11. 18.11GE Healthcare
    12. 18.12Hitachi, Ltd.
    13. 18.13Integrity Medical Systems, Inc.
    14. 18.14Koninklijke Philips N.V.
    15. 18.15Master Medical Equipment (Pvt) Ltd.
    16. 18.16Pacific Healthcare Imaging, Inc.
    17. 18.17Radiology Oncology Systems, Inc.
    18. 18.18Siemens Healthineers AG
    19. 18.19SOMA TECH INTL, Inc.
    20. 18.20TRACO
    21. 18.21US Med‑Equip, Inc.
    22. 18.22Whittemore Enterprises, Inc.
  19. 19.Key Experts

Loading the sample request form…